MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 120 filers reported holding MAXCYTE INC in Q3 2023. The put-call ratio across all filers is 10.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,318,387 | -28.0% | 422,560 | +6.0% | 0.01% | -27.8% |
| Q2 2023 | $1,830,400 | +20.1% | 398,780 | +29.5% | 0.02% | +20.0% |
| Q1 2023 | $1,524,229 | +3.3% | 307,925 | +14.0% | 0.02% | 0.0% |
| Q4 2022 | $1,474,883 | +2.5% | 270,125 | +22.0% | 0.02% | -6.2% |
| Q3 2022 | $1,439,000 | +169.5% | 221,325 | +95.9% | 0.02% | +220.0% |
| Q2 2022 | $534,000 | -93.9% | 113,000 | -90.9% | 0.01% | -93.2% |
| Q1 2022 | $8,697,000 | -34.5% | 1,244,272 | -4.5% | 0.07% | -25.3% |
| Q4 2021 | $13,281,000 | -23.0% | 1,303,321 | -7.7% | 0.10% | -23.3% |
| Q3 2021 | $17,247,000 | – | 1,412,564 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $17,608,500 | 11.83% |
| Vitruvian Partners LLP | 5,043,356 | $27,536,724 | 5.80% |
| NORTH RUN CAPITAL, LP | 451,960 | $2,467,702 | 5.67% |
| Casdin Capital, LLC | 9,505,000 | $51,897,300 | 4.02% |
| RIVER GLOBAL INVESTORS LLP | 1,648,238 | $8,749 | 1.88% |
| Pier Capital, LLC | 1,074,164 | $5,864,935 | 0.96% |
| Montanaro Asset Management Ltd | 929,000 | $4,915,460 | 0.80% |
| First Light Asset Management, LLC | 1,365,343 | $7,454,773 | 0.69% |
| Stonepine Capital Management, LLC | 273,287 | $1,492,147 | 0.63% |
| Mudita Advisors LLP | 90,201 | $492,498 | 0.43% |